
South India Drugs Export And Laboratory Private Limited
Pharmaceutical trading company based in Chennai, Tamil Nadu.
Pharmaceutical trading company based in Chennai, Tamil Nadu.
South India Drugs Export And Laboratory Private Limited (SIDEALPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 January 2006 and has a history of 19 years and one month. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.06 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeevi Ethirajulu, Geetha Thiagarajan, Elavazhagan Govindasamy, and Two other members serve as directors at the Company.
Kanchipuram, Tamil Nadu, India
+91-XXXXXXXXXX
U51397TN2006PTC058620
058620
Private Limited Indian Non-Government Company
23 Jan 2006
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjeevi Ethirajulu ![]() | Managing Director | 23-Jan-2006 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Geetha Thiagarajan ![]() | Director | 23-Jan-2006 | Current |
Elavazhagan Govindasamy ![]() | Director | 28-Feb-2011 | Current |
Bhramanantha Jayaraman ![]() | Director | 28-Feb-2011 | Current |
Kuili Jayaraman ![]() | Director | 28-Feb-2011 | Current |
South India Drugs Export And Laboratory Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.12% increase. The company also saw a substantial fall in profitability, with a 22.33% decrease in profit. The company's net worth moved up by a moderate rise of 9.49%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, South India Drugs Export And Laboratory had a promoter holding of 62.22% and a public holding of 37.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Kuili Jayaraman is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with South India Drugs Export And Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of South India Drugs Export And Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped South India Drugs Export And Laboratory's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
South India Drugs Export And Laboratory Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
South India Drugs Export And Laboratory Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.
Elavazhagan Govindasamy was appointed as a Director was appointed as a Director on 28 Feb 2011 & has been associated with this company since 14 years 11 days .
Bhramanantha Srikumar Jayaraman was appointed as a Director was appointed as a Director on 28 Feb 2011 & has been associated with this company since 14 years 11 days .
Kuili Rajarajeswari Jayaraman was appointed as a Director was appointed as a Director on 28 Feb 2011 & has been associated with this company since 14 years 11 days .
Geetha Thiagarajan was appointed as a Director was appointed as a Director on 23 Jan 2006 & has been associated with this company since 19 years 1 month .
South India Drugs Export And Laboratory Private Limited was incorporated on 23 Jan 2006.
The authorized share capital of South India Drugs Export And Laboratory Private Limited is ₹ 3.50 M and paid-up capital is ₹ 3.06 M.
Currently 5 directors are associated with South India Drugs Export And Laboratory Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of South India Drugs Export And Laboratory Private Limited is No.16 Nethaji Road Ganesh Nagar Adampakkam, India, Chennai, Tamil Nadu, 600088.
The corporate identification number (CIN) of South India Drugs Export And Laboratory Private Limited is U51397TN2006PTC058620 and the company number is 058620 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for South India Drugs Export And Laboratory Private Limited has risen by 1.12%.
The financial reports for the fiscal year 2023 indicates that The net worth of South India Drugs Export And Laboratory Private Limited has experienced an upsurge of 9.49%.
The most recent Balance Sheet for South India Drugs Export And Laboratory Private Limited was filed with the ROC on 31 Mar 2023.
SV
SM
CB
BN